Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06RNU
|
|||
Drug Name |
Quinazoline derivative 2
|
|||
Synonyms |
PMID27607364-Compound-46
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C17H15N3O2
|
|||
Canonical SMILES |
CN(C)C(=O)OC1=NC(=NC2=CC=CC=C21)C3=CC=CC=C3
|
|||
InChI |
1S/C17H15N3O2/c1-20(2)17(21)22-16-13-10-6-7-11-14(13)18-15(19-16)12-8-4-3-5-9-12/h3-11H,1-2H3
|
|||
InChIKey |
NAXSAPGEPBKPDD-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Translocator protein (TSPO) | Target Info | Ligand | [1] |
Target's Patent Info | Translocator protein (TSPO) | Target's Patent Info | [1] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
HTLV-I infection |
References | Top | |||
---|---|---|---|---|
REF 1 | Translocator protein (TSPO) ligands for the diagnosis or treatment of neurodegenerative diseases: a patent review (2010-2015; part 1).Expert Opin Ther Pat. 2016 Nov;26(11):1325-1351. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.